XML 26 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Activities    
Net Income $ 394 $ 397
Adjustments to reconcile Net Income to Net cash from operating activities:    
Depreciation and amortization 358 368
Nuclear fuel amortization 3 15
Allowance for equity funds used during construction (8) (7)
Deferred income taxes 18 41
Equity (earnings) losses of equity method investees 11 (32)
Dividends from equity method investees 1 42
Asset (gains) losses and impairments, net 0 1
Changes in assets and liabilities:    
Accounts receivable, net 18 107
Inventories 129 52
Prepaid postretirement benefit costs (27) (15)
Accounts payable (42) (20)
Gas inventory equalization 108 68
Accrued pension liability (25) (24)
Accrued postretirement liability (8) (3)
Derivative assets and liabilities 108 126
Regulatory assets and liabilities (154) 128
Other current and noncurrent assets and liabilities (76) (187)
Net cash from operating activities 808 1,057
Investing Activities    
Plant and equipment expenditures — utility (737) (630)
Plant and equipment expenditures — non-utility (27) (39)
Proceeds from sale of assets 0 1
Proceeds from sale of nuclear decommissioning trust fund assets 207 271
Investment in nuclear decommissioning trust funds (209) (273)
Distributions from equity method investees 2 4
Contributions to equity method investees (1) (2)
Notes receivable (8) (27)
Other (9) (10)
Net cash used for investing activities (782) (705)
Financing Activities    
Issuance of long-term debt, net of discount and issuance costs 1,119 989
Redemption of long-term debt (250) 0
Short-term borrowings, net (514)  
Short-term borrowings, net   14
Repurchase of common stock (55) (54)
Dividends paid on common stock (171) (210)
Contributions from noncontrolling interests 1 12
Distributions to noncontrolling interests (5) (14)
Other (30) (35)
Net cash from financing activities 95 702
Net Increase in Cash, Cash Equivalents, and Restricted Cash 121 1,054
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 35 516
Cash, Cash Equivalents, and Restricted Cash at End of Period 156 1,570
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable $ 300 $ 208